Create Alert
Watchlist

Ind Swift

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹101Cr
ROE-1.94%
P/E Ratio(TTM)0.36
EPS(TTM)52.33
P/B Ratio0.00
Dividend Yield0.00%
Industry P/E36.00
Book Value-74.28
Debt to Equity-2.17
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Ind Swift

Ind Swift Limited is an India-based pharmaceutical manufacturing and marketing company. The Company operates in both domestic and export markets. It is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The Company is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. It operates through various divisions, such as Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte. The Company also provides a range of COVID19 products, including masks, travel kits, hand sanitizers, and gloves. It has also launched two products, Stevia (natural sweetener) and Hangover (helps avoid alcoholic hangover). The Company also has five plants in India. ;
Parent OrganisationInd Swift
Managing DirectorDr. Gopal Munjal
NSE SymbolINDSWFTLTD

Shareholding Pattern

Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Promoters
55.58%
Retail And Others
44.42%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
61.31
Ajanta Pharma
NA
(0.00%)
37.82
Gland Pharma
NA
(0.00%)
46.48
Eris Lifesciences
NA
(0.00%)
68.64